Cost-Effectiveness Analysis of Ofatumumab versus Teriflunomide for Relapsing-Remitting Multiple Sclerosis: A 10-Year Markov Model
Ziyad Saeed Almalki,1 Mashael Mafleh Alshammari,2 Saja H Almazrou,2 Ohud Abd Alhadi Alqahtani,3 Maryam Riyadh Alkhayat,3 Shahad Fahad Alnemari,3 Haya Showky Mukhemair,3 Sara Mohamaad Alkredeas,3 Abdulrahman A Alsuhibani,4 Bushra Yousif Asiri,3 Tala Nouraldin Dash Cam Alalawi,3 Abdullah K Alahmari,1 Fahad Obaid Alotaibi5 1Department of Clinical Phar